MedCity News

JANUARY 24, 2024

By partnering with a cloud managed service provider, one can overcome cloud staffing and security issues and better align internal resources with the things that make your business special, like developing new apps and features that enhance healthcare services and improve health outcomes for end users.

Management 111

Management Healthcare Healthcare Specialization 111

MedCity News

NOVEMBER 28, 2023

Developed as part of the due diligence process for the disclosure of confidential documents, VDRs provide a secure repository for all types of confidential materials including merger and acquisition (M&A) documents, financial statements, contracts, intellectual property details, and legal agreements.

Medical 115

Medical 115

Pharmaceutical Technology

JANUARY 19, 2024

BridgeBio Pharma has secured strategic financing of $1.25bn from Blue Owl Capital and CPP Investments for genetic therapies.

Pharma 98

Pharma 98

Pharmaceutical Technology

FEBRUARY 28, 2024

Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405 for hair loss.

Medicine 104

Medicine Pharmaceutical 104

Referral MD

FEBRUARY 15, 2024

In the digital age, where communication is instant and seamless in most industries, healthcare has often lagged due to concerns about privacy and security. Photo by JoshuaWoroniecki on Pixabay What is the Role of Direct Secure Messaging in Healthcare? So, how does Direct Secure Messaging work? ” Direct Trust Blog Post.

Healthcare 52

Healthcare Healthcare Healthcare Provider Electronics 52

Pharmaceutical Technology

APRIL 18, 2024

Theolytics has concluded a funding round securing a total of £19m ($24.5m) to advance its oncolytic adenovirus therapy, THEO-260.

52

52

European Pharmaceutical Review

AUGUST 23, 2022

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

Medicine 93

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 93

MedCity News

NOVEMBER 10, 2023

Utilizing innovative technologies to prevent workplace violence and enhance security in healthcare has the potential to increase staffing retention, ultimately improving hospital operations, administration, and the healthcare industry as a whole.

Healthcare 111

Healthcare Healthcare 111

Pharmaceutical Technology

APRIL 16, 2024

Qureight has secured $8.5m in a Series A funding round led by Hargreave Hale AIM VCT to accelerate drug development.

52

52

Pharmaceutical Technology

MARCH 27, 2024

Avenzo Therapeutics has secured $150m in Series A-1 financing round to progress the development of its oncology pipeline.

59

59

Fierce Pharma

APRIL 3, 2024

Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug.

FDA 261

FDA Pharmaceutical 261

Pharmaceutical Technology

JUNE 5, 2023

Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health. While it is unreasonable to expect the level of security in the nuclear sector, we should have checks and balances at every step, creating a new level of assurance.”

Pharma 110

Pharma Food and Drug Administration Insurance Pharmaceutical 110

MedCity News

NOVEMBER 1, 2022

Indiana University Health has begun working with healthcare technology company TRIMEDX to test the security of connected medical devices at the health system’s medical device security lab.

Medical 111

Medical Healthcare Healthcare 111

MedCity News

SEPTEMBER 1, 2023

By optimizing data collection and synthesis, securely sharing data, and ensuring equitable access, we can make significant strides towards delivering more personalized, effective, and patient-centered care. The fusion of clinical and engagement data can revolutionize the way we understand and treat patients.

Patients 122

Patients 122

Fierce Pharma

JANUARY 29, 2024

New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days. | New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days.

Biopharma 310

Biopharma 310

MedCity News

AUGUST 31, 2022

In fact, a new report shows that many healthcare organizations could be overestimating their level of cloud security. The threats of ransomware and phishing are more prevalent than ever, but not all healthcare providers have appropriately adjusted their strategies to mitigate increasing risk.

Healthcare Provider 107

Healthcare Provider Healthcare Healthcare 107

Impetus Digital

DECEMBER 5, 2022

Digital health data security is a growing concern for individuals, organizations, and government agencies. In fact, this is one of the challenges for the industry – balancing security and access. The good news is that each of these challenges presents an opportunity to better the current and future health data security.

Healthcare 94

Healthcare Healthcare Medical Electronics 94

MedCity News

MARCH 2, 2023

Disgruntled investors lodged fewer securities claims against life-science companies last year. But when they did sue, investors raised familiar issues, often tied to bad news around clinical research and regulatory approvals, according to a law firm report

Biopharma 114

Biopharma 114

Pharmaceutical Technology

MARCH 7, 2024

Alumis secured $259m in a Series C funding round to develop its clinical-stage pipeline of therapies designed to address immune dysfunction.

59

59

Fierce Pharma

NOVEMBER 22, 2022

Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule. Tue, 11/22/2022 - 10:22.

FDA 146

FDA 146

Fierce Pharma

APRIL 8, 2024

Merely hours after Bristol Myers Squibb’s Abecma secured the FDA’s blessing to break into earlier treatment of multiple myeloma, Johnson & Johnson and Legend Biotech’s Carvykti received a simil | Merely hours after Bristol Myers Squibb’s Abecma secured the FDA’s blessing to break into earlier treatment of multiple myeloma, Johnson & Johnson (..)

Manufacturing 277

Manufacturing 277

Fierce Pharma

MARCH 28, 2024

An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. | An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S.

296

296

European Pharmaceutical Review

FEBRUARY 13, 2024

First CRISPR-based gene-editing therapy authorised The post Vertex secures European approval for CRISPR cell therapy appeared first on European Pharmaceutical Review.

Pharmaceutical 90

Pharmaceutical Patients FDA Marketing 90

Pharmaceutical Technology

MARCH 4, 2024

FogPharma has secured $145m in a Series E financing round to support the clinical development of its cancer therapy, FOG-001.

52

52

Pharmaceutical Technology

MARCH 1, 2024

BlossomHill has secured $100m in a Series B financing round to advance its programmes targeting cancer and autoimmune diseases.

52

52

MedCity News

DECEMBER 20, 2022

This security measure can help decrease an organization’s attack surface, create accurate response automation and prevent the compromise. As with most industries, healthcare should consider adopting a zero-trust approach.

Healthcare 131

Healthcare Healthcare 131

Fierce Pharma

FEBRUARY 29, 2024

Venture capital firms pitching in on drug development isn’t exactly a new way of doing business for the biopharma industry. Venture capital firms pitching in on drug development isn’t exactly a new way of doing business for the biopharma industry. But a new funding pact between Carlyle’s Abingworth and Gilead Sciences is somewhat unconventional.

Biopharma 271

Biopharma Pharma 271

Pharmaceutical Technology

FEBRUARY 14, 2024

BioAge Labs has secured $170m in an Series D funding round to progress the development of therapeutics for obesity and metabolic diseases.

52

52

MedCity News

OCTOBER 11, 2022

Cybercriminals are weaponizing the same tools that healthcare providers use to operate and maintain secure IT systems, HHS warned in a recent report. Providers can protect themselves by having a firm grasp of what their IT environment looks like, as this may help them spot any suspicious security tool commands.

Healthcare Provider 128

Healthcare Provider Healthcare Healthcare 128

Pharmaceutical Technology

FEBRUARY 2, 2024

LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.

52

52

Fierce Pharma

MARCH 18, 2024

As bluebird bio works to make the most of three gene therapy launches, cash-flow concerns have been looming over the drugmaker. | The funding should extend bluebird bio's cash runway through the first quarter of 2026 as it advances three gene therapy launches.

235

235

MedCity News

JUNE 22, 2023

Organizations across most industries, especially the technology sector, have adopted Multi-Factor Authentication (MFA) to fortify their security measures.

Healthcare 97

Healthcare Healthcare 97

Pharmaceutical Technology

JANUARY 18, 2024

Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing radiotherapies for cancer treatment.

52

52

Pharmaceutical Technology

JUNE 30, 2023

BioMarin’s Roctavian, a one-time therapy for severe haemophilia A, has secured FDA approval following previous rejections and delays.

FDA 97

FDA 97

Pharmaceutical Technology

MARCH 5, 2024

Nocion has secured $62m in Series B financing round to advance its lead programme, Taplucanium, into later-stage development.

Leads 52

Leads 52

Fierce Pharma

APRIL 19, 2024

The Swiss pharma has now secured an FDA approval in the post-surgical setting as it continues to test the drug in additional patient populations. Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer.

FDA 293

FDA Pharma Patients 293

Pharmaceutical Technology

JULY 25, 2023

Boehringer Ingelheim and Eli Lilly have secured approval from the EC for Jardiance to treat adults with chronic kidney disease (CKD).

98

98